Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 11—November 2017
Research Letter

Chlamydia trachomatis Biovar L2 Infection in Women in South Africa

Remco P.H. Peters1Comments to Author , Ronan Doyle1, Mathys J. Redelinghuys, James A. McIntyre, Georges M. Verjans, Judith Breuer, and Marleen M. Kock
Author affiliations: University of Pretoria, Pretoria, South Africa (R.P.H. Peters, M.J. Redelinghuys, M.M. Kock):; Maastricht University Medical Centre, Maastricht, the Netherlands (R.P.H. Peters); Anova Health Institute, Johannesburg, South Africa (R.P.H. Peters, J.A. McIntyre); University College London, London, United Kingdom (R. Doyle, J. Breuer); University of Cape Town, Cape Town, South Africa (J.A. McIntyre); Erasmus Medical Centre, Rotterdam, the Netherlands (G.M. Verjans); National Health Laboratory Service, Pretoria (M.M. Kock)

Main Article

Table

Characteristics of 7 women with vaginal discharge and a positive PCR result for Chlamydia trachomatis biovar L, Pretoria, South Africa, 2012–2016*

Patient
ID Healthcare setting HIV status Co-infection C. trachomatis WGS result Mean read depth Genome coverage, %
1 ART clinic Positive Trichomonas vaginalis L2 confirmed 41 99.5
2 ART clinic Positive T. vaginalis L2 confirmed 12 98.3
3 ART clinic Positive Mycoplasma genitalium L2 confirmed 21 98.6
4 ART clinic Positive M.a genitalium L2 confirmed 72 99
5 ART clinic Positive T. vaginalis Insufficient WGS read coverage 0.5 29
6 STI clinic Unknown Neisseria gonorrhoeae Insufficient clinical material ND ND
7
 STI clinic
 Unknown
 N. gonorrhoeae
 Insufficient clinical material
 ND
 ND
*ART, antiretroviral therapy; ID, identification; ND, not determined; STI, sexually transmitted infection; WGS, whole-genome sequencing.

Main Article

1These authors contributed equally to this article.

Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external